Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Matucci

Showing results (121-130 of 295) with videos related to

Pageof 30
Sort By:
The Journal of Rheumatology|October 24, 2001
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot studyP Sambo, D Amico, R Giacomelli, et al.
Reumatismo|April 22, 2011
Treatment patterns of anti-TNF agents in Italy: an observational studyL Punzi, M Matucci Cerinic, F Cantini, et al.
Clinical and Experimental Rheumatology|November 6, 2010
The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliabilityA Del Rosso, S Maddali-Bongi, F Sigismondi, et al.
Reumatismo|October 8, 2004
[Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society]C Salvarani, I Olivieri, F Cantini, et al.
Il Farmaco; Edizione Pratica|August 1, 1983
Pharmacokinetics of factor VIII:C. Appropriateness of the one-compartment model for estimating clearanceM Matucci, G Longo, M Morfini, et al.
Annals of the Rheumatic Diseases|May 18, 2005
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approachL Robertson, A Pignone, O Kowal-Bielecka, et al.
Endothelium : Journal of Endothelial Cell Research|June 12, 1999
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?F Falcini, S Generini, A Pignone, et al.
Journal of Internal Medicine|June 1, 1992
Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritisA Pignone, M Matucci-Cerinic, M Morfini, et al.
Rheumatology International|January 1, 1993
Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?M Matucci-Cerinic, A Lombardi, G Leoncini, et al.
Annals of the Rheumatic Diseases|November 22, 2007
Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertensionF Iannone, M T Riccardi, S Guiducci, et al.
Pageof 30

Showing results (121-130 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Rheumatology|October 24, 2001
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot studyP Sambo, D Amico, R Giacomelli, et al.
Reumatismo|April 22, 2011
Treatment patterns of anti-TNF agents in Italy: an observational studyL Punzi, M Matucci Cerinic, F Cantini, et al.
Clinical and Experimental Rheumatology|November 6, 2010
The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliabilityA Del Rosso, S Maddali-Bongi, F Sigismondi, et al.
Reumatismo|October 8, 2004
[Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society]C Salvarani, I Olivieri, F Cantini, et al.
Il Farmaco; Edizione Pratica|August 1, 1983
Pharmacokinetics of factor VIII:C. Appropriateness of the one-compartment model for estimating clearanceM Matucci, G Longo, M Morfini, et al.
Annals of the Rheumatic Diseases|May 18, 2005
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approachL Robertson, A Pignone, O Kowal-Bielecka, et al.
Endothelium : Journal of Endothelial Cell Research|June 12, 1999
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?F Falcini, S Generini, A Pignone, et al.
Journal of Internal Medicine|June 1, 1992
Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritisA Pignone, M Matucci-Cerinic, M Morfini, et al.
Rheumatology International|January 1, 1993
Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?M Matucci-Cerinic, A Lombardi, G Leoncini, et al.
Annals of the Rheumatic Diseases|November 22, 2007
Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertensionF Iannone, M T Riccardi, S Guiducci, et al.
Pageof 30